Jazz Pharmaceuticals (JAZZ) Operating Margin (2010 - 2026)
Jazz Pharmaceuticals' quarterly Operating Margin came in at 31.49% in Q1 2026, up 3772.0% year-on-year from 0.81% in Q1 2025, and up 48.2% quarter-over-quarter from 21.25% in Q4 2025.
Jazz Pharmaceuticals has reported Operating Margin for 17 years, with the latest figure at 31.49% in Q1 2026.
- For the quarter ending Q1 2026, Operating Margin rose 3772.0% year-over-year to 31.49%; the trailing twelve-month figure through Mar 2026 stood at 0.85% (down 1548.0% YoY), and the FY2025 full-year result was 10.08%, down 2769.0% from the prior year.
- Operating Margin for Q1 2026 stood at 31.49%, up from 21.25% in the prior quarter.
- The five-year high for Operating Margin was 31.49% in Q1 2026, with the low at 65.64% in Q2 2025.
- Average Operating Margin over 5 years is 6.52%, with a median of 12.11% recorded in 2023.
- Year-over-year, Operating Margin soared 3920 bps in 2023 and sank 8512 bps in 2025.
- Tracing JAZZ's Operating Margin over 5 years: stood at 27.09% in 2022, then soared by 145 bps to 12.11% in 2023, then soared by 45 bps to 17.53% in 2024, then rose by 21 bps to 21.25% in 2025, then soared by 48 bps to 31.49% in 2026.
- The last three Operating Margin figures came in at 31.49% (Q1 2026), 21.25% (Q4 2025), and 5.11% (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Operating Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -6.43% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 38.10% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 17.83% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 23.02% |
| 10 | Jazz Pharmaceuticals | 14.35 Bn | 12.51 Bn | 934.80 Mn | 31.49% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 31.49% |
| Dec 31, 2025 | 21.25% |
| Sep 30, 2025 | 5.11% |
| Jun 30, 2025 | -65.64% |
| Mar 31, 2025 | -6.23% |
| Dec 31, 2024 | 17.53% |
| Sep 30, 2024 | 24.67% |
| Jun 30, 2024 | 19.48% |
| Mar 31, 2024 | 7.34% |
| Dec 31, 2023 | 12.11% |
| Sep 30, 2023 | 17.73% |
| Jun 30, 2023 | 16.47% |
| Mar 31, 2023 | 14.12% |
| Dec 31, 2022 | -27.09% |
| Sep 30, 2022 | 2.63% |
| Jun 30, 2022 | 9.17% |
| Mar 31, 2022 | 10.76% |
| Dec 31, 2021 | 5.51% |
| Sep 30, 2021 | 3.38% |
| Jun 30, 2021 | -9.26% |
| Mar 31, 2021 | 26.68% |
| Dec 31, 2020 | 26.06% |
| Sep 30, 2020 | 32.65% |
| Jun 30, 2020 | 35.23% |
| Mar 31, 2020 | -35.47% |
| Dec 31, 2019 | 10.53% |
| Sep 30, 2019 | 24.75% |
| Jun 30, 2019 | 38.25% |
| Mar 31, 2019 | 26.32% |
| Dec 31, 2018 | 38.84% |
| Sep 30, 2018 | 40.22% |
| Jun 30, 2018 | 30.61% |
| Mar 31, 2018 | 19.75% |
| Dec 31, 2017 | 32.36% |
| Sep 30, 2017 | 20.99% |
| Jun 30, 2017 | 41.85% |
| Mar 31, 2017 | 36.20% |
| Dec 31, 2016 | 41.73% |
| Sep 30, 2016 | 36.41% |
| Jun 30, 2016 | 44.27% |
| Mar 31, 2016 | 36.06% |
| Dec 31, 2015 | 31.28% |
| Sep 30, 2015 | 38.59% |
| Jun 30, 2015 | 45.93% |
| Mar 31, 2015 | 37.75% |
| Dec 31, 2014 | 39.59% |
| Sep 30, 2014 | 18.93% |
| Jun 30, 2014 | 25.51% |
| Mar 31, 2014 | -27.00% |
| Sep 30, 2013 | 43.31% |
| Jun 30, 2013 | 37.01% |
| Mar 31, 2013 | 34.75% |
| Dec 31, 2012 | 36.68% |
| Sep 30, 2012 | 31.51% |
| Jun 30, 2012 | 31.74% |
| Mar 31, 2012 | 34.86% |
| Dec 31, 2011 | 45.09% |
| Sep 30, 2011 | 46.67% |
| Jun 30, 2011 | 53.35% |
| Mar 31, 2011 | 44.43% |
| Dec 31, 2010 | 30.57% |
| Sep 30, 2010 | 19.71% |
| Jun 30, 2010 | 16.39% |